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ABSTRACT: This report describes the clinical and laboratorial findings as well as the therapeutic protocol performed in a 
three-year-old mongrel female intact dog, referred to the Veterinary Hospital of FAMEZ/UFMS. The animal had a previous 
history of recurrent gastrointestinal signs (such as lethargy, vomiting, loss of appetite, melena and abdominal pain), acute cri-
sis episodes, bradycardia, hypotension, hypothermia and increase of capillary refill time, recognized as addisonian crisis due 
to primary hypoadrenocorticism. Laboratorial findings included anemia, eosinophilia, neutrophilia, lymphocytosis, sodium-
potassium ratio of 14,02 mEq/L and prerenal azotemia. Based on that, it was confirmed the diagnosis of primary hypoadre-
nocorcitism. Thus, it was recommended supplementation therapy with mineralocorticoid (aldosterone) and glucocorticoid 
(cortisol) corresponding respectively, fludrocortisone acetate of 0.2 mg per kg of BW, by mouth, once daily and prednisone 
0.2 mg per kg of BW, by mouth, twice daily until further recommendations. The prognostic was excellent, since the animal 
significantly improved body condition, andclinical signs disappeared after therapy which lead the sodium-potassium ratio to 
35.11 mEq/L. Thus, the clinician must always suspect of primary hypoadrenocorticism in dogs with intermittent nonspecific 
signs that get better with support therapy. Presumably, hypoarenocorticism must be under diagnosed in veterinary medicine, 
reinforcing the need to require specific exams in patients that show this wax and wane feature of clinical signs. 
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HIPOADRENOCORTICISMO PRIMÁRIO EM UM CÃO
RESUMO: O presente relato descreve os achados clínicos, laboratoriais e conduta terapêutica de um animal da espécie cani-
na, fêmea, com três anos de idade, inteiro, sem raça definida, diagnosticado com hipoadrenocorticismo primário atendido no 
Hospital Veterinário da FAMEZ/UFMS. O animal apresentou histórico de recidivas de sinais gastrintestinais (letargia, vômi-
tos, perda de apetite, melena e dor abdominal), crise adrenal aguda, bradicardia, hipotensão, hipotermia e aumento do tempo 
de preenchimento capilar. As alterações laboratoriais compreenderam linfocitose, anemia, eosinofilia, neutrofilia, densidade 
urinária < 1.030, relação sódio: potássio 14,02 mEq/L e azotemia pré-renal. Baseado nos achados clínicos-laboratoriais 
confirmou-se o hipoadrenocorticismo primário. Em seguida, foi instituído terapia de suplementação de mineralocorticoide 
(aldosterona) e glicocorticoide (cortisol), correspondendo respectivamente ao acetato de fludrocortisona na dose de 0,2 mg/
kg por via oral uma vez ao dia e prednisona 0,2 mg/kg por via oral duas vezes por dia até novas recomendações. O prog-
nóstico foi excelente para este caso, já que houve melhora significativa do animal, com o desaparecimento dos sinais clínicos 
e com nova relação sódio: potássio de 35,11 mEq/L. Assim, deve-se sempre suspeitar de hipoadrenocorticismo primário 
canino em pacientes com o curso de aparecimento e desaparecimento com sinais inespecíficos que melhorem com terapia de 
suporte. Presume-se que o hipoadrenocorticismo primário em cães seja subdiagnosticado na medicina veterinária, por isso 
a importância dos clínicos em suspeitar e solicitar exames específicos em pacientes que apresentam esse curso da doença.
PALAVRAS-CHAVE: Cães. Endocrinopatias. Glicocorticoides. Mineralocorticoides. Relação sódio: potássio. Síndrome de 
Addison.
HIPOADRENOCORTICISMO PRIMARIO EN UN PERRO
RESUMEN: El informe describe los hallazgos clínicos, de laboratorio y manejo terapéutico de un perro, hembra, con tres 
años de edad, entera, mestizo, con diagnóstico de hipoadrenocorticismo primario atendido en el Hospital Veterinario de la 
FAMEZ/UFMS. El animal tuvo un historial de signos gastrointestinales recurrentes (letargia, vómitos, pérdida de apetito, 
melena y dolor abdominal), crisis renal aguda, bradicardia, hipotensión, hipotermia y un aumento del tiempo de llenado 
capilar. Las alteraciones de laboratorio presentaron linfocitosis, anemia, eosinofilia, neutrofilia, densidad de la orina < 1,030, 
relación sodio: potasio 14,02 mEq/L y azotemia prerrenal. Con base en los hallazgos clínicos y de laboratorio, se confirmó el 
hipoadrenocorticismo primario. A continuación, se introdujo terapia con administración de mineralocorticoide (aldosterona) 
y glucocorticoide (cortisol), que correspondieron respectivamente al acetato de fludrocortisona a una dosis de 0,2mg/kg por 
vía oral una vez al día y prednisona 0,2 mg/kg por vía oral dos veces al día hasta nuevas recomendaciones. El pronóstico fue 
excelente para este caso, ya que hubo mejora significativa del animal, desapareciendo los signos clínicos y con una nueva 
relación sodio: potasio de 35,11 mEq/L. Por lo tanto, siempre se debe sospechar del hipoadrenocorticismo primario canino 
en pacientes con el curso de aparecimiento y desaparecimiento con signos inespecíficos que mejoran con terapia de soporte. 
Es posible que el hipoadrenocorticismo primario en perros sea diagnosticado en la medicina veterinaria, así la importancia de 
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Introduction
Hypoadrenocorticism (HA) or Addison’s diseases, 
is an uncommon disease, with an estimate incidence be-
tween 0.06% and 0.28% (KELCH et al., 1998) caused by 
deficiency of adrenal secretion of mineralocorticoid and/or 
glucocorticoid (SCOTT-MONCRIEFF, 2015). Addison’s di-
sease has been referred to as “the great pretender” due to its 
ability to mimic other common diseases in dogs representing 
a diagnostic challenge (KLEIN; PETERSON, 2010a). HA 
can be caused by the destruction of the adrenal cortex or, 
less commonly, by the deficiency of the production of adre-
nocorticotropic hormone (ACTH) (FELDMAN; NELSON, 
1996; PETERSON; KINTZER, 1996). It is believed that the 
immune-mediate adrenalitis is the most common etiology for 
the spontaneous cases of primary canine HA (SCHAER et 
al., 1986). Main findings in affected dogs were severe lym-
phoplasmacytic inflammation and atrophy of all layers of the 
adrenal cortex (FRANK et al., 2013). Other rare causes in-
cluded granulomatosis destruction, amyloidosis, hemorrha-
ge, metastatic neoplasm (LABELLE; DE COCK, 2005; RO-
CKWELL et al., 2005; REUSCH et al., 2007; FRANK et al., 
2013) and the use of drugs as mitotane and trilostane which 
induce the adrenal glands necrosis (REUSCH et al., 2007). 
In secondary HA, the cause is due to the inade-
quate secretion of ACTH by pituitary gland, leading to the 
deficiency of synthesis and secretion of adrenocortical hor-
mones, mainly the glucocorticoids (SCOTT-MONCRIEFF, 
2015).
There is sexual predilection, in which 70% of the 
affected dogs are female (PETERSON; KINTZER, 1996; 
MELIÁN et al., 1999). Young-to-middle age bitches with 
mean of four years of age are the most affected animals (PE-
TERSON; KINTZER, 1996). History of gastrointestinal epi-
sodes that improve with support therapy should alert the ve-
terinarians of the possibility of HA, especially if the signs are 
intermittent (SCOTT-MONCRIEFF, 2015). The stimulation 
test with ACTH must be considered as part of the diagnostic 
plan in dogs with intermittent signs of lethargy, vomiting, 
diarrhea and weight loss (LIFTON; KING; ZERBE, 1996).
The clinical syndrome occurs when at least 90% of 
the adrenocortical tissue is destroyed causing deficiency of 
mineralocorticoids (aldosterone) and glucocorticoids (corti-
sol) (KLEIN; PETERSON, 2010b; SCOTT-MONCRIEFF, 
2015). The lack of aldosterone is presumable in dogs with 
hypocortisolemia, hyponatremia and hyperkalemia. Howe-
ver, there are some dogs with HA that may show normal elec-
trolyte concentration even in face of decreasing aldosterone 
concentration (BAUMSTARK et al., 2014). Once most dogs 
with HA undergo cortisol and aldosterone deficiency, routi-
ne diagnostic is based on cortisol measurement test. Other 
classic laboratorial findings include normocytic normochro-
mic anemia, lymphocytosis, hyponatremia and hyperkale-
mia; however, these abnormalities not always are present 
(SCOTT-MONCRIEFF, 2015).
Treatment of primary HA consists of supplementa-
tion with mineralocorticoids and glucocorticoids (PETER-
SON; KINTZER, 1997). Prognosis for both primary and 
secondary HA is usually excellent, but guarded for patients 
with neoplasms. Age, breed and body weight do not influence 
survival time. The most important factor in relation to long-
-term recovery is the care the owner dispenses to the animal 
(SCOTT-MONCRIEFF, 2015).
The aim of this report was to describe the clinical 
and laboratorial findings as well as the therapeutic protocol 
performed in a three-year-old mongrel female intact dog 
diagnosed with primary HA. 
Case report
A three-year-old mongrel female intact dog, wei-
ghing 13 kilos was referred to the Veterinary Hospital of the 
Faculty of Veterinary Medicine and Zootechny of the Fede-
ral University of Mato Grosso do Sul. The animal arrived at 
the emergency section of the Hospital with cardiopulmonar 
arrest. After the reanimation technique, the animal remained 
in stupor. The physical exam showed bradycardia (<40bpm), 
hypothermia (35.1ºC), increase capillary refill time (CRT) 
and hypotension (unable to be measured).
She was put on emergency therapy with intensive 
fluid therapy (sodium chloride 0.9% solution), 60ml/kg/hour 
in the first two hours, continuous infusion of dobutamine 
10µg/kg/minute and intravenous glucocorticoid (dexameta-
sone) at dose of 0.2 mg/kg. Complete blood cell and bioche-
mical evaluation (albumin, alanine aminotransferase [ALT], 
alkaline phosphate [ALP], BUN and creatinine) have were 
solicited. The only abnormality found was azotemia (BUM: 
80 mg/dL; range value [21,4-59,9] and creatinine: 3,24 mg/
dL; range value [0,5-1,5 mg/dL]). Two days after intensive 
care, the animal was sent home without clinical signs. 
After 15 days, the animal returned to the hospital 
with history of vomiting, loss of appetite and shaking. The 
new exams showed the persistency of azotemia so that she 
was put on fluid therapy with sodium chloride 0.9% solution, 
and sent home two days after admission. Few days later, the 
animal returned with lethargy, vomiting, shaking, abdominal 
pain and loss of appetite. At this moment, there was a suspi-
cion of pancreatitis because the owner referred the animal 
did the “prayer position” at home. Abdominal ultrasound and 
thoracic radiographs (lateral and ventrodorsal views) have 
been performed. There were no abnormalities in the abdomi-
nal ultrasound; radiographs showed a slight decreased size of 
the heart with VHS (Vertebral Heart Size) of 9.0. Blood exa-
ms revealed lymphocytosis (7.748mm³ [1.000-4.800mm³]). 
In urinary evaluation, it was observed urine specific gravity 
of 1.020, little protein content, 15 leucocytes per field, and 
bacteriuria. 
Due to these alterations, clinician prescribed sco-
polamine (Buscopan®) at 0.4 mg by mouth once daily for 
seven days, dipirone at 25 mg/kg by mouth every eight hours 
for five days, amoxiciline at 22mg/kg by mouth twice a day 
during 10 days and proper nutrition.  
The patient had several episodes of nonspecific 
signs from December 2013 to February 2014 as showed in 
los clínicos en sospechar y solicitar exámenes específicos en pacientes que presentan ese curso de la enfermedad. 
PALAVRAS CLAVE: Endocrinopatias. Enfermedad de Addison. Glucocorticoide. Mineralocorticoide. Perros. Relación 
sodio: potasio.
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table 1.Laboratorial abnormalities detected were normocytic 
normochromic anemia, lymphocytosis (ranging from 5,590 
to 8,492mm³; range value [1,000-4,800 mm³]), neutrophi-
lia, eosinophilia and azotemia. Albumin, ALP and ALT did 
not show any alterations. Therefore, after the second severe 
crisis, we suspected of primary HA, so that serum concen-
trations of sodium and potassium have been analysed and 
turned to be 115 mEq/L and 8.2 mEq/L, respectively, with 
sodium-potassium ratio of 14.02 mEq/L, that lead to the con-
firmation of primary HA. 
It was instituted the fludrocortisone acetate treat-
ment at a dose of 0.02mg/kg once daily by mouth and predni-
sone at 0.2 mg/kg twice daily until further recommendations. 
After this treatment, the animal did not show any clinical 
signs and after 15 days, as she returned for reevaluation, 
the new sodium-potassium ratio was 35.11 mEq/L. Thirteen 
months later, the dog is still under medication with no clini-
cal signs and a good quality of life. 
Table 1: Clinical signs of a dog with primary HA showing commonly wax and wane history referred to the Veterinary Hos-
pital of FAMEZ during 2013-2014.
Consultations at HV Lethargy Vomiting Shaking Loss of appetite Abdominal pain Melena
05/11/13 (D0) * - - - - - x
20/11/13 (D15) - x x x - -
28/11/13 (D23) x - x x x -
02/12/13 (D27) x x x x x -
30/01/14 (D86) x x x x x -
20/02/14 (D107) x x x x - -
27/02/14 (D114) x - - - - -
28/02/14 (D115) * - x - - - x
*Presumably an addisonian crisis. Hypothermia, bradycardia, hypotension and increased capillary refill time.
Discussion
The studied animal is a three-year old female which 
corroborates the findings of Peterson and Kintzer (1996). Al-
though literature cites some breeds in which the disease has a 
genetic autosomal recessive feature, as Standard Poodle and 
Nova Scotia Duck Tolling Retriever (SCOTT-MONCRIEFF, 
2010), the animal of this case was a mongrel dog. 
Clinical signs can be acute or insidious in onset and 
commonly wax and wane, and could be triggered by a stres-
sful event (SCOTT-MONCRIEFF, 2015). Such intermittent 
feature of clinical presentation lead the clinicians to a de-
lay in determining the final diagnosis. The animal presen-
ted several recurrent episodes of gastrointestinal signs and 
other nonspecific signs such as shaking, lethargy and loss 
of appetite. Furthermore, throughout the completely moni-
toring period, it was observed two episodes of addisonian 
crisis (acute adrenal crisis) consisting of hypovolemic shock 
with hypotension, bradycardia (< 40bpm), hypothermia and 
increased capillary refill time. All these manifestations are 
according to Peterson and Kintzer (1996), Melián and Peter-
son (1996) and Lifton, King and Zerbe (1996), which related 
anorexia, vomiting, lethargy/depression, weakness, weight 
loss, diarrhea, shaking, polyuria, polydipsia, abdominal pain, 
hypovolemic shock, collapse, hypothermia, bradycardia, me-
lena and dehydration as common signs in patients with HA. 
Less commonly, it may occur seizures due to hypoglycemia, 
muscle cramps and gastrointestinal bleeding (MEDINGER 
et al., 1993; LEVY, 1994; SYME; SCOTT-MONCRIEFF, 
1998; SAITO et al., 2002), but these signs were not present 
in our patient.
Thereby, the history of recurrent episodes of gas-
trointestinal diseases (as lethargy, vomiting, diarrhea and/
or dehydration) which improved with support therapy (fluid 
therapy and administration of corticoid) were indicative of 
HA, as reports of Scott-Moncrieff (2015).It is believed that 
the pathogenesis of gastrointestinal signs in dogs with HA 
are multifactorial. Glucocorticoids deficiency results in le-
thargy, weakness, hypotension, hypoglycemia, anorexia, vo-
miting, weight loss, decreased mobilization of proteins and 
fat leading to muscle weakness and inability to maintain the 
integrity and endothelial vascular tone (ROMÃO; ANTU-
NES, 2012; SCOTT-MONCRIEFF, 2015). 
Although the basal cortisol has not been determined 
in this report, it is assumed that it should be somehow de-
creased, due to clinical signs and good response after admi-
nistration of dexamethasone, with significant improvement 
of general condition. According to Lennon et al. (2007), the 
concentration of plasm cortisol has a high negative predictive 
value and can be used to rule out the diagnosis of HA. In that 
same report, the authors say that values ≤ 1µg/dL present an 
excellent sensitivity (100%) and specificity (98.2%) to detect 
dogs with HA.  
Laboratory changes found in this report inclu-
de normocytic, normochromicanemia, eosinophilia, lym-
phocytosis, prerenal azotemia, urine density gravity 1.020, 
hyperkalemia and hyponatremia, with sodium-potassium 
ratio of 14.02 mEq/L. These findings corroborate the ones 
reported by Scott-Moncrieff (2010) and Melián and Peter-
son (1996).The urine specific gravity may be low (<1.030), 
but not so low when compared to those found in dogs with 
primary kidney disease (SCOTT-MONCRIEFF, 2010). Besi-
des, the presence of leukocytes and protein could justify the 
increased urine specific gravity of the animal in this report. 
Despite it has not been measured the concentration 
of chlorine, electrolyte changes such as hyponatremia and 
hyperkalemia found here are in accordance with Peterson et 
al. (1996). The low sodium:potassium ratio observed in this 
case was determinant for the suspicion of HA, once the usu-
al  ratio ranges from 27:1 to 40:1 (SCOTT-MONCRIEFF, 
2015),and values lower than 24:1 (ADLER et al., 2007)or 
20:1 (SETH et al., 2011) correspond to 100% specificity for 
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the diagnosis of HA. However, other studies have identified 
that the proportion of dogs with sodium:potassium ratio lo-
wer than 24:1 that suffered from HA varied from 17% to 24% 
of the animals, suggesting that other diseases may also cause 
changes in sodium:potassium ratio (ROTH; TYLER, 1999; 
NIELSEN et al., 2008).
In a retrospective study of 225 dogs with HA, 96% 
of them had hyperkalemia and 81% hyponatremia (PETER-
SON et al., 1996).
Unfortunately, the owner had not authorized the sti-
mulation test with ACTH in this case, because of its high 
cost. However, clinical signs, laboratory changes and thera-
peutic response confirmed the disease, as affirmed by Lathan 
and Tyler (2005), who said that diagnosis is based on history 
findings, clinical signs, laboratory changes and evaluation of 
adrenocortical reserve. 
In addition, another study noted that the lymphocyte 
count was 100% sensitive and more specific for the detection 
of HA than the sodium:potassium ratio (SETH et al., 2011), 
as found in this case report, in which there was lymphocyto-
sis during the course of the disease.
During the addisonian crisis, emergency manage-
ment was carried out as recommended by Scott-Moncrieff 
(2015), based on fluid therapy with sodium chloride 0.9% 
solution IV between 40 to 80 ml/kg/hour for the first two 
hours, dexamethasone (0.1 to 0.2 mg/kg IV), as well as he-
matological and biochemical profile. Unfortunately, it was 
not performed the measurement of basal cortisol, urinalysis 
and dosages of sodium and potassium. 
There has been significant improvement of the cli-
nical signs with treatment and after diagnosis of HA the ani-
mal was sent home with both supplementation drugs (fludro-
cortisone acetate and prednisone) for life. 
The main factor that led us to a delayed diagnosis 
was the fact that the HA can mimic other diseases, as liver 
failure (hypoglycemia, hypoalbuminemia, hypocholestero-
lemia and increased ALT and ALP), renal failure (anemia, 
azotemia, hyperkalemia, hyperphosphatemia and decreased 
of urine specific gravity), insulinoma (hypoglycemia, incre-
ased ALT and ALP), protein-losing enteropathy (hypoalbu-
minemia, hypocolesterolemia and non-regenerative anemia). 
Thus, unless the veterinarian keep high index of suspicion 
for the diagnosis of HA, the diagnosis is often lost (SCOTT-
-MONCRIEFF, 2015). As the addisonian crisis represents a 
serious life-threatening complication which can lead to dea-
th, it is mandatory an immediate veterinarian’s intervention 
(ROMÃO; ANTUNES, 2012).
Conclusions
Dogs with clinical and laboratory findings sugges-
tive of primary HA should be carefully investigated, in order 
not be masked by other diseases, since many signs are nons-
pecific, recurrent and reverted with support therapies. The 
clinicians must therefore include HA in the list of differential 
diagnosis of all animals, especially those who showepisodes 
of weakness, gastrointestinal signs, azotemia, bradycardia, 
hypotension, and laboratorial changes such as low Na: K ra-
tio, lymphocytosis and low urine specific gravity.
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